BridgeMD
New treatment option for Chronic Kidney Disease
Official title Evaluation of Cardiovascular Risk Factors in Incident Dialysis Patients
ClinicalTrials.gov ID: NCT02813642
What this study is testing
What is Plasma osteoprotegerin level?
Plasma osteoprotegerin level is an investigational medicine, being studied as a potential treatment for chronic kidney disease.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- To evaluate the relationships between bone mineral markers levels at dialysis start and vascular calcification progression during a 2 year follow up
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 90
You may be able to join if
- Patient who has signed the written consent form
- Patient with chronic renal failure starting dialysis therapy
You likely can't join if
- Pregnancy
- Patient with chronic renal failure not yet on dialysis therapy
The study team makes the final eligibility decision.
Where it's taking place
- Castelnau-le-Lez, France
- Montpellier, France
- Nîmes, France
- Perpignan, France
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 90 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Castelnau-le-Lez, France; Montpellier, France; Nîmes, France; Perpignan, France. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.